# Anavex Life Sciences Corp.: Form 8-K, filed May 24, 2023

- Company: [Anavex Life Sciences Corp.](/companies/avxl.md) (CIK 1314052)
- Form: 8-K
- Filed: 2023-05-24
- Accepted by EDGAR: May 24, 2023, 20:30 ET
- Period: 2023-05-23
- Accession: 0001731122-23-001007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1314052/000173112223001007/e4737_8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1314052/000173112223001007/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1314052/000173112223001007/e4737_8-k.htm

Filed May 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001731122-23-001007. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.